Fortfahren mit
Größe auswählen
| Größe/SKU | Verfügbarkeit | Preis |
|---|
Über diesen Artikel
grade
pharmaceutical primary standard
agency
USP
API family
orlistat
manufacturer/tradename
USP
application(s)
pharmaceutical
format
neat
SMILES string
N([C@@H](CC(C)C)C(=O)O[C@H]1[C@@H](C(=O)O[C@H](C1)CCCCCCCCCCC)CCCCCC)C=O
InChI
1S/C29H53NO5/c1-5-7-9-11-12-13-14-15-16-18-24-21-27(25(28(32)34-24)19-17-10-8-6-2)35-29(33)26(30-22-31)20-23(3)4/h22-27H,5-21H2,1-4H3,(H,30,31)/t24-,25-,26-,27+/m0/s1
InChI key
IYWNIYFHQZQPBP-YIPNQBBMSA-N
General description
Application
- Orlistat
- Orlistat Capsules
Analysis Note
Other Notes
1 of 1
Dieser Artikel | |||
|---|---|---|---|
| description United States Pharmacopeia (USP) Reference Standard | description reference material, pharmaceutical secondary standard | description United States Pharmacopeia (USP) Reference Standard | description United States Pharmacopeia (USP) Reference Standard |
| grade pharmaceutical primary standard | grade reference material, pharmaceutical secondary standard | grade pharmaceutical primary standard | grade pharmaceutical primary standard |
| manufacturer/tradename USP | manufacturer/tradename - | manufacturer/tradename USP | manufacturer/tradename USP |
| format neat | format - | format neat | format neat |
| application(s) pharmaceutical | application(s) pharmaceutical small molecule | application(s) pharmaceutical (small molecule) | application(s) pharmaceutical |
| agency USP | agency - | agency USP | agency USP |
| API family orlistat | API family - | API family rivaroxaban | API family tolnaftate |
signalword
Danger
Hazard Classifications
Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Eye Irrit. 2 - Flam. Liq. 2
Lagerklasse
3 - Flammable liquids
flash_point_f
35.6 °F - closed cup
flash_point_c
2.0 °C - closed cup
Hier finden Sie alle aktuellen Versionen:
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.



